[Human growth hormone for treatment of children and adolescents. Crakow school experience].
The author presents the experience of the Crakow endocrine school in the treatment of children and adolescents with diagnosed in infancy Growth Hormone Deficiency by use of the recombinant Human Growth Hormone. She underlines the diagnostic and therapeutic controversies and actual statements of the World Growth Forum endocrinologists concerning the changes of "gold standards" in diagnostics of GHD. The necessity of the prolongation of rhGH treatment in adolescents and adults with congenital GHD has been stressed.